Semnur Pharmaceuticals, Inc. (SMNR)
OTCMKTS · Delayed Price · Currency is USD
9.00
-10.00 (-52.63%)
At close: Oct 1, 2025
Semnur Pharmaceuticals Statistics
Total Valuation
SMNR has a market cap or net worth of 2.63 billion. The enterprise value is 2.68 billion.
| Market Cap | 2.63B |
| Enterprise Value | 2.68B |
Important Dates
The next estimated earnings date is Friday, December 26, 2025.
| Earnings Date | Dec 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SMNR has 292.48 million shares outstanding.
| Current Share Class | 292.48M |
| Shares Outstanding | 292.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 41.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -59.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -718.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.19
| Current Ratio | 6.19 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -48.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.74M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.35% in the last 52 weeks. The beta is 0.34, so SMNR's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -22.35% |
| 50-Day Moving Average | 12.19 |
| 200-Day Moving Average | 9.03 |
| Relative Strength Index (RSI) | 40.40 |
| Average Volume (20 Days) | 651 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.74M |
| Pretax Income | -3.74M |
| Net Income | -3.74M |
| EBITDA | n/a |
| EBIT | -3.74M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 55,000 in cash and 52.17 million in debt, giving a net cash position of -52.12 million or -0.18 per share.
| Cash & Cash Equivalents | 55,000 |
| Total Debt | 52.17M |
| Net Cash | -52.12M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | -44.45M |
| Book Value Per Share | -0.28 |
| Working Capital | 7.04M |
Cash Flow
| Operating Cash Flow | -1.96M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SMNR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.14% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |